Central Bank of India has received approval from the Competition Commission of India (CCI) for its proposed acquisition of additional equity in two insurance subsidiaries. The CCI's approval, communicated via a letter dated March 3, 2026, pertains to the acquisition of 1.09% additional equity in Generali Central Insurance Company Limited (GCICL) and 0.82% additional equity in Generali Central Life Insurance Company Limited (GCLICL). Following the completion of this acquisition, Central Bank of India's shareholding in GCICL will increase from the current 24.91% to 26%. Similarly, its stake in GCLICL will rise from the existing 25.18% to 26%. This disclosure follows up on a previous intimation made by the bank on November 6, 2025. The bank has requested that this information be taken on record.
